Skip to main content
. 2017 Dec 8;52(2):119–124. doi: 10.1007/s13139-017-0496-3

Fig. 1.

Fig. 1

A 51-year-old male with rectal NET who underwent low anterior resection. Post-surgery Ga-DOTATATE PET/CT showed extensive somatostatin receptor-avid metastases in the liver, abdominal and pelvic lymph nodes, and bones (A, C and D). He was started on subcutaneous long-acting octreotide. Six months later, his Ga-DOTATATE PET/CT showed progression of disease particularly in the liver (B, E and F). He was subsequently referred for peptide receptor chemoradionuclide therapy (PRCRT)